UPDATE: Zyomyx, Fujirebio Partner to Develop, Market Protein Chips | GenomeWeb

This story has been updated from a previous version.

NEW YORK, Nov 16 – Zyomyx said Thursday it had penned an agreement with Fujirebio of Tokyo to co-develop and market protein biochips that could be used as diagnostic and screening tools.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.